500MG/30MG TBL NOB 30
Announcement of launch, break or close-out of marketing of a medicinal product
|Type of announcement||Effective date||Alternate medicines ?||Reason for interruption/cessation of marketing||Estimated renewal date|
|Resumption of marketing||05.10.2022|
|Interruption of marketing||27.09.2022||
|Resumption of marketing||08.01.2020|
|Interruption of marketing||24.10.2019||
All reports are available in the Overview.